<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2C59BC00-FAE0-480E-A069-AD23ACA83EBA"><gtr:id>2C59BC00-FAE0-480E-A069-AD23ACA83EBA</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Steel</gtr:surname><gtr:orcidId>0000-0002-2493-5826</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/65C5317E-E907-428E-9765-2E1073316D40"><gtr:id>65C5317E-E907-428E-9765-2E1073316D40</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Whiting</gtr:surname><gtr:orcidId>0000-0001-8937-8445</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/182A5057-1680-4484-9989-084823B85CC6"><gtr:id>182A5057-1680-4484-9989-084823B85CC6</gtr:id><gtr:firstName>Todd</gtr:firstName><gtr:surname>Marder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FF068158%2F1"><gtr:id>7C55229B-7913-4C10-9705-76E11A15C00E</gtr:id><gtr:title>New array strategies using C-H borylation chemistry</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/F068158/1</gtr:grantReference><gtr:abstractText>In order to evaluate and optimise (small) molecules for a particular function, e.g. as a drug molecule, it is necessary to prepare a range of analogues that differ in structure. This is known as an array and the efficient synthesis of such arrays requires reactions that can be used on multiple samples simultaneously. The variety of chemical reactions currently used in array preparation is limited and the research in this project is designed to address this need based on chemistry of the boronic acid functional group. In particular we will develop new array synthetic strategies using direct catalytic C-H borylation chemistry. This requires evaluation of new substrate classes and an optimisation of the catalysts to give better selectivity and reactivity. This will provide sets of new boronic acids from unfunctionalised aromatic and heteroaromatic precursors. In addition, the boronic acids are themselves used in many synthetic transformations and we will explore using the arrays of boronic acids as starting points for a further generation of array synthesis.</gtr:abstractText><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>504222</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>CASE collaboration with GSK</gtr:description><gtr:id>1E5367A7-AC00-4A71-892B-710C44E160CC</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>545d0b687ad3b2.37753730-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input - Industrial supervision - industrial secondment</gtr:partnerContribution><gtr:piContribution>Academic research results</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>24000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Astra Zeneca Case Award</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>2ADD1870-C497-419B-8AD6-52C5A8071B2F</gtr:id><gtr:outcomeId>58b541de8ade59.70052723</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>used at GSK by DU researcher on placement to explore library enrichment strategies - reported in primary literature</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>425BB420-331B-41BC-835D-70CC2F824CAB</gtr:id><gtr:impactTypes/><gtr:outcomeId>56d5d69f533089.84382842</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>C-H borylation can be an efficient method for the late stage generation of analogues of drug like molecules - pharmaceutical leads</gtr:description><gtr:exploitationPathways>similar transformations are now being used in other drug discovery programmes</gtr:exploitationPathways><gtr:id>BBF24628-41BB-433F-A765-A43A00A620FA</gtr:id><gtr:outcomeId>56d5d758ac8fd0.59852612</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1F304840-3ADF-4566-9ABF-12DA5B680EFE</gtr:id><gtr:title>Iridium-catalyzed C-H borylation of quinolines and unsymmetrical 1,2-disubstituted benzenes: insights into steric and electronic effects on selectivity</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b72c27df20d4d9c53b53f9a203044063"><gtr:id>b72c27df20d4d9c53b53f9a203044063</gtr:id><gtr:otherNames>Tajuddin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d02f02fe32d708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F84198-CF6D-4495-B346-EC46C1286A71</gtr:id><gtr:title>Multidirectional Synthesis of Substituted Indazoles via Iridium-Catalyzed C-H Borylation.</gtr:title><gtr:parentPublicationTitle>The Journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef1c16f5ba01e82953595e57f5261a7"><gtr:id>aef1c16f5ba01e82953595e57f5261a7</gtr:id><gtr:otherNames>Sadler SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3263</gtr:issn><gtr:outcomeId>58b5416f1bb6f2.86631281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E1AC645-B2E1-4C24-95AB-12A18AED3F8B</gtr:id><gtr:title>&amp;quot;One-pot&amp;quot; tandem C-H borylation/1,4-conjugate addition/reduction sequence.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b72c27df20d4d9c53b53f9a203044063"><gtr:id>b72c27df20d4d9c53b53f9a203044063</gtr:id><gtr:otherNames>Tajuddin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>545d095a824839.41455172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D65594-B326-429C-9229-CF2DD1E22E00</gtr:id><gtr:title>Iridium-catalyzed C-H borylation of pyridines.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef1c16f5ba01e82953595e57f5261a7"><gtr:id>aef1c16f5ba01e82953595e57f5261a7</gtr:id><gtr:otherNames>Sadler SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>541a8b2f67ce65.33177164</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/F068158/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D59C2DC2-AD17-4980-92F3-677EB001B765</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Combinatorial Chemistry</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>